MILIND DESHPANDE

Profile

First Name

: MILIND

Middle Name

:

Last Name

: DESHPANDE

Related Companies

Titles

Company Name

Related People

DIRECTOR

SPERO THERAPEUTICS, LLC

CASPER BREUM, JEAN-FRANCOIS FORMELA, STEPHEN GARBACZ, VIKAS GOYAL, REZA HALSE, KAMAL HAMED, SCOTT JACKSON, TAMARA JOSEPH, TIMOTHY KEUTZER, CRISTINA LARKIN, ANKIT MAHADEVIA, DAVID MELNICK, JOHN C. POTTAGE, JR., SATYAVRAT SHUKLA, CYNTHIA SMITH, FRANK E. THOMAS, KATHLEEN TREGONING, PATRICK VINK

EXECUTIVE OFFICER, DIRECTOR

NAYAN THERAPEUTICS, INC.

ROBERT MILLMAN, DAVID NEAFUS, JOSHUA RESNICK

DIRECTOR, EXECUTIVE OFFICER

SANTI THERAPEUTICS, INC.

NATHANIEL BROOKS HORWITZ, SHELLEY CHU, DAVID GRAYZEL, ANDREW HEDIN, LORENCE KIM, ANDREW LEVIN, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER

EXECUTIVE OFFICER, DIRECTOR

AVILAR THERAPEUTICS, INC.

THERESA CAMERON, MARTIN FREED, PHIL GRAHAM, DANIEL GRAU, PAULINA HILL, ADAM MUZIKANT, DAVID NEAFUS, JOSHUA RESNICK, STEPHANIE TOZZO

DIRECTOR

SPERO THERAPEUTICS, INC.

CASPER BREUM, JEAN-FRANCOIS FORMELA, STEPHEN GARBACZ, VIKAS GOYAL, REZA HALSE, KAMAL HAMED, SCOTT JACKSON, TAMARA JOSEPH, TIMOTHY KEUTZER, CRISTINA LARKIN, ANKIT MAHADEVIA, DAVID MELNICK, JOHN C. POTTAGE, JR., SATYAVRAT SHUKLA, CYNTHIA SMITH, FRANK E. THOMAS, KATHLEEN TREGONING, PATRICK VINK

DIRECTOR, EXECUTIVE OFFICER

TRIANA BIOMEDICINES, INC.

NATHANIEL BROOKS HORWITZ, SHELLEY CHU, DAVID GRAYZEL, ANDREW HEDIN, LORENCE KIM, ANDREW LEVIN, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2020-12-14

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2022-11-07

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2022-01-28

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2022-01-28

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2021-09-03

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2021-06-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2020-12-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2020-05-22

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-02-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-03-07